William Hayde, of Legendary NY Based Beverage Merchant Bank IBC, Joins Board.

Co-Founder of Legendary Intercontinental Beverage Capital Inc., (IBC) Joins Forces with Life On Earth (LFER).

Read the full article here

Big news today that William Hayde the co-founder of the well known NY based Merchant Bank focused specifically on the beverage and consumer packaged goods industries, joined Life On Earths Board of Directors.

IBC counts many of the top beverages experts in the world on its team, from which Mr. Hayde can tap for advice related to financing, strategic advisory, packaging and design, management and more.

IBC is a New York-based advisory and investment firm with representative offices in Atlanta, Boca Raton, Los Angeles, and Lugano, Switzerland.

The veteran industry experts at IBC have worked with Companies from small start-ups to industry giants such as Triarc, Snapple, Cadbury Schweppes, Red Bull, Brown-Forman, Anheuser-Busch, Coca-Cola, Guinness, Bespoke Brands, Fuze, SmartWater, NOS, VitaminWater and more.

IBC, one of the leading beverage advisory firms in North America, has quietly expanded its footprint and influence in the cannabis beverage sector over the last year. The spread of medical and recreational cannabis in the U.S., and now Canada, indicates they’re on the right track, particularly in regard to cannabis-infused non-alcoholic craft beers and other non-alcohol beverages containing CBD. 

Life On Earth additionally announced today that it has brought on board industry veterans, Peter Dacey, as its new Chief Financial Officer.

Mr. Peter Dacey was a founder and the Chief Executive Officer of Miami Bay Beverage Company, LLC, which successfully developed and launched the Trimino brand of protein-infused waters. Trimino is currently sold through key distributors to more than 10,000 retail outlets. “In joining Life On Earth’s management team, I feel this is a company that will become the next big story in the CPG space. There are a lot of opportunities that the company can capture in order to expand its business exponentially this year and in the future.

Prior to 454 Life Sciences, Peter served as CFO for publicly traded biotechnology companies Stem Cells Inc. and CytoTherapeutice Inc. Peter was responsible for raising in excess of $50M through public offerings for these organizations. Peter also spent several years with Ernst & Young LLP specializing in the entrepreneurial and technology sectors.